RxDoctor Payments Data

Daniel Hurd, DO

Dermatology · Blacksburg, VANPI 1841290897

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $461,207 of the $545,400 with a category attached, or 84.6%. 29 manufacturers reported payments, led by Lilly USA, LLC at 39.5% of the total. Among dermatology clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$545,400in general payments, 2019–2025

Across 792 payments — averaging $688.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$215K
  • AbbVie$122K
  • E.r. Squibb & Sons, L.L.C.$62K
  • Regeneron Healthcare Solutions, Inc.$61K
  • Novartis$24K
  • Dermavant Sciences, Inc.$22K
  • plus $40K from 23 others

What the payments were for

  • Consulting fees$20,1744%
  • Speaking & faculty fees$461,20785%
  • Travel & lodging$48,2529%
  • Food & beverage$15,3683%
  • Education$4000%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$545,400 in reported general payments places this provider in the 95th percentile of 396 dermatology providers in Virginia.

See all dermatology providers in Virginia

Medicare billing

Part B allowed, 2024
$2,144,918
Medicare patients
5,460
Services billed
30,658

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent SyringeDupilumab25$93,170
Cosentyx Sensoready (2 Pens)Secukinumab12$84,320
Fluorouracil83$6,560
Clobetasol Propionate77$2,563
Metronidazole33$1,954
ValacyclovirValacyclovir Hcl31$970
Clindamycin Phosphate20$869
Cephalexin227$856
Dutasteride27$769
Ketoconazole41$548
Doxycycline Hyclate36$513
Fluconazole28$483
Triamcinolone Acetonide34$421
Hydroxychloroquine Sulfate22$228
MethotrexateMethotrexate Sodium18$121

Paid to pharmacies, not to this prescriber.

Other dermatology in Blacksburg

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →